Article

The Japan TimesThe Japan Times on 2020-05-12 06:51

Abe follows Trump’s example approving drugs quickly after criticism

Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.

Related news